Narcolepsy in Children: Overcoming Barriers and Improving Outcomes
October 01, 2019
Narcolepsy in Children
1.00 Credits
Non-Statin Therapy for LDL-Cholesterol Reduction in Primary and Secondary Prevention
May 21, 2019
2.00 Credits
Managing LDL-C to Reduce Cardiovascular Disease Risk: Defining Best Clinical Practice
April 22, 2019
In this program, an expert faculty will discuss the evidence and recommendations for managing LDL-C in patients with ASCVD, familial hypercholesterolemia (FH), diabetes, and those at increased cardiovascular risk without ASCVD.
2.00 Credits
CROSSROADS OF CARE: Facing the Challenges of Heart Failure and Diabetes
April 01, 2019
In this symposium, Dr. James Januzzi and Dr. Mikhail Kosiborod will explain the intertwined relationship between diabetes and HF, and interpret safety and effi cacy data, focusing on HF-related outcomes, from studies with diabetes therapies.
1.00 Credits
Diabetes Therapies Exploring Mechanisms and Role of the Cardiovascular Clinician in CVD Risk Management
March 24, 2019
1.00 Credits
Hyperkalemia and Heart Failure: Recognizing Risks and Exploring Strategies for Improving Outcomes
February 24, 2019
In this program, Dr. Paul Hauptman and Dr. Javed Butler will 1) describe the relationship between RAAS inhibitors, hyperkalemia, and cardiovascular risk, 2) identify goals and treatments for acute, intermediate, and chronic management, and 3) discuss the clinical profi les of, and clinical settings for the use of, new potassium binders.
CME 1.00 Credits
Narcolepsy in Children: Insights into Diagnosis and Strategies to Improve Patient Care
December 30, 2018
In this program, pediatric sleep disorder experts Dr. Kiran Maski and Dr. Merrill Wise will describe strategies to overcome barriers in diagnosing narcolepsy in children, and explain best practices in treatment including emerging evidence with pharmacologic therapy.
1.00 Credits
Fine-tuning the Management of Narcolepsy and Excessive Daytime Sleepiness in Obstructive Sleep Apnea
August 23, 2018
This program will focus on the diagnosis and treatment of narcolepsy and EDS in OSA. Format will consist of state-of-the-art lectures and debates chaired by Michael Thorpy, MD with faculty Michael Sateia, MD; Thomas Scammell, MD,Kingman Strohl, MD; Phyllis Zee, MD, PhD
No Credit Available
LDL-Cholesterol Lowering and Atherosclerotic Cardiovascular Disease Risk Reduction: Exploring the Evidence With Non-Statin Therapy
June 17, 2018
n this program, lipid experts will present, in state-of-the-art lectures and in 'realworld' interactive cases, optimal strategies and provide 'take-home' messages for reducing risk in patients with elevated LDL-C.
No Credit Available